argenx SE
resulted in higher responses than placebo on analysis of response criteria consistent with previous platelet response results | argenx SE
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
9 of 15
Related slides by other companies
AstraZeneca
Investor Day
February 2022
fact quality of life over time | AstraZeneca
Aeglea BioTherapeutics
Investor Presentation
February 2022
primary met marked and sustained reduction in plasma arginine | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Results
December 2021
primary met marked and sustained reduction in plasma arginine | Aeglea BioTherapeutics
NeuroSense Therapeutics
Investor Presentation
January 2024
slowed the loss of physical functions placebo a | NeuroSense Therapeutics
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io